FindTrial
Sign In

Nimbaphala Vati In Madhumeha

OPEN LABEL SINGLE ARM CLINICAL STUDY ON EFFICACY OF NIMBAPHALA VATI (Azadirachta indica Juss) AS MADHUMEHAHARA (ANTIDIABETIC ACTIVITY) IN TYPE II DIABETES MELLITUS. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103221
Enrollment
30
Registered
2026-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

SDM College of Ayurveda and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects above 30 years up to 60 years of either gender suffering from Type 2 Diabetes Mellitus will be taken. Fasting Blood Sugar MORE THAN OR EQUAL TO 126 mg/dL. Post Prandial Blood Sugar MORE THAN OR EQUAL TO 200 mg/dL. Those patients willing to participate in the study and who are ready to sign the informed consent form.

Exclusion criteria

Exclusion criteria: Subjects with Type 2 Diabetes Mellitus who are on insulin. Subjects With Diabetic complications like Diagnosed Diabetic foot, Diagnosed Diabetic Retinopathy, Diagnosed Diabetic Neuropathy, Diagnosed Diabetic Nephropathy and other secondary complications. Patients with impaired Cardiac, Hepatic and Renal Functions. Pregnant and Lactating woman.

Design outcomes

Primary

MeasureTime frame
To evaluate the Madhumehahara Karma of Nimba Phala Vati as Madhumehahara Karma in Type 2 Diabetes MellitusTimepoint: 3 months—

Secondary

MeasureTime frame
NilTimepoint:—

Countries

India

Contacts

Public ContactDR MOUNESHWAR P PATTAR

SRI DHARMASTHALA MANJUNATHESHWARA COLLEGE OF AYURVEDA AND HOSPITAL HASSAN

mouneshpp123@gmail.com7026203030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026